Hyperpolarized 13 C MRI: Path to Clinical Translation in Oncology.

MLA

Kurhanewicz, John, et al. “Hyperpolarized 13 C MRI: Path to Clinical Translation in Oncology.” Neoplasia (New York, N.Y.), vol. 21, no. 1, Jan. 2019, pp. 1–16. EBSCOhost, https://doi.org/10.1016/j.neo.2018.09.006.

APA

Kurhanewicz, J., Vigneron, D. B., Ardenkjaer-Larsen, J. H., Bankson, J. A., Brindle, K., Cunningham, C. H., Gallagher, F. A., Keshari, K. R., Kjaer, A., Laustsen, C., Mankoff, D. A., Merritt, M. E., Nelson, S. J., Pauly, J. M., Lee, P., Ronen, S., Tyler, D. J., Rajan, S. S., Spielman, D. M., … Rizi, R. (2019). Hyperpolarized 13 C MRI: Path to Clinical Translation in Oncology. Neoplasia (New York, N.Y.), 21(1), 1–16. https://doi.org/10.1016/j.neo.2018.09.006

Chicago

Kurhanewicz, John, Daniel B Vigneron, Jan Henrik Ardenkjaer-Larsen, James A Bankson, Kevin Brindle, Charles H Cunningham, Ferdia A Gallagher, et al. 2019. “Hyperpolarized 13 C MRI: Path to Clinical Translation in Oncology.” Neoplasia (New York, N.Y.) 21 (1): 1–16. doi:10.1016/j.neo.2018.09.006.